Myriad Genetics Stock Price (NASDAQ:MYGN)

Add to My Stocks
$19.38 $0.23 (1.2%) MYGN stock closing price Mar 24, 2017 (Closing)
YOUR DAILY UPDATE ON
MYGN
Myriad Genetics
24 MAR 2017
amigobulls logo
MYGN hand_up
MYGN vs S&P 500
Closing Price: Mar 24, 2017
MYGN
$19.38 ( 1.2%)
S&P 500
2344 ( -0.08%)
MYGN
52 Week Price Range
1 Year Return: -47.32%
Q2 Growth*
Poor
Profitable ?
Yes
net image
2017 Q2 Net Profit
8.1%
PE Valuation
Cheaper*
home image
Rating
MYGN EXCELLENT
☆ ☆ ☆ ☆ ☆★ ★ ★ ★ ★
Double Tap To Exit Full Screen
0:00
/

Myriad Genetics Snapshot Video

12 5 2

MYGN Stock Details

Prev Close* : $19.15
Market Cap:
$1.32B
Day Low: $19.07
52 Week Low: $15.15
Open: $19.22
Volume: 920668
Day High: $19.49
52 Week High: $39.74
Dividend:
N/A

Latest Stock Market News

Latest Articles

Myriad Genetics News - From Partners

MYGN Stockcharts

View MYGN PE ratio, PS ratio stocks charts and compare with peers.
MYGN Chart
Note: Compare Myriad Genetics stock price history with the index and industry peers.

Myriad Genetics Valuation

PE ratio
(price earnings ratio)
23.35
PS ratio (
price to sales ratio
)
1.76
PB ratio (
price to book ratio
)
1.76

Myriad Genetics Returns

ROE
(return on equity)
8%

Myriad Genetics Financial Ratios

Asset Turnover
0.62
Receivables Turnover
7.62
Debt to Equity
0.28

MYGN Industry Peers

Company Price Change (%)
Innoviva (INVA)12.850.06 (0.46%)
Axovant Sciences (AXON)14.910.16 (1.08%)
Foundation Medicine (FMI)32.90.8 (2.49%)
Oncocyte (OCX)5.780.02 (0.34%)
Genomic Health (GHDX)31.560.48 (1.54%)
Interleukin Genetics (ILIU)0.120 (0%)
Fulgent Genetic (FLGT)110.01 (0.09%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
Enzo Biochem (ENZ)8.430.52 (6.57%)
Peregrine Pharma (PPHM)0.7060.03 (4.44%)
Ophthotech (OPHT)3.530.15 (4.44%)
Kindred Biosciences (KIN)7.20.3 (4.35%)
Fortress Biotech (FBIO)3.60.14 (4.05%)
Immunomedics (IMMU)6.880.25 (3.77%)
Compugen (CGEN)4.350.15 (3.57%)
Top gainers from Medical-Biomed-Genetics industry
* As of Mar 25, 2017
CompanyPriceChange (%)
BioDelivery Sciences (BDSI)1.750.18 (9.35%)
Vital Therapies (VTL)3.850.15 (3.75%)
MannKind (MNKD)1.890.06 (3.08%)
PDL BioPharma (PDLI)1.980.05 (2.46%)
Sangamo BioSciences (SGMO)4.10.1 (2.38%)
Sorrento Therapeutics (SRNE)4.10.1 (2.38%)
Ultragenyx Pharma (RARE)70.321.67 (2.32%)
Top losers from Medical-Biomed-Genetics industry
* As of Mar 25, 2017

Myriad Genetics, Inc. Stock News - Partner Headlines

Myriad Genetics Financial Statements

income statement20162015201420132012
Net Sales Or Revenues753.8M723.1M778.21M613.16M496M
Net Income125.3M80.2M176.22M147.13M112.15M
Total Operating Expense429.7M441.5M394.56M305.53M251.02M
view Myriad Genetics, Inc. income statement
balance sheet20162015201420132012
Total Assets880.5M766.2M823.81M803.82M690.63M
Total Liabilities132.4M104.1M104.81M75.22M54.97M
Shareholders Equity748.1M662.1M718.99M728.59M635.66M
view Myriad Genetics, Inc. balance sheet
cash flow statement20162015201420132012
Net Increase (Decrease) In Assets Liabilities-65.4M-40.7M-59.97M-41.02M-28.76M
Net Cash From (Used By) Operating Activities166.3M140.5M190.21M173.86M141.84M
Increase (Decrease) In Prop Plant And Equipment-5M-23.9M-14.27M-11.37M-9.4M
view Myriad Genetics, Inc. cashflow statement

Myriad Genetics Stock Message Board

An investor needs to spend 19.38 to buy MYGN stock, as the closing Myriad Genetics stock price is 19.38. Myriad Genetics market capitalization is 1.3B and it represents the total market value of MYGN stock. Myriad Genetics valuation can be different from its intrinsic stock price when viewed from a value investors perspective.

The stock price movement of a company indicates what investors are willing to pay. For Ex: if investors feel that Myriad Genetics is worth a lot, it will most likely be reflected in an inflated Myriad Genetics stock quote, and vice versa. However, it must be noted that a company's value must not be equated to its share price. 920668 MYGN shares were traded yesterday, and Myriad Genetics stock chart shows that the MYGN stock quote hit a day high of 19.49 and day low of 19.07. Dividends are usually paid by large stable companies, and typically not by those which are in their rapid growth stages. A company's continuing success is indicated by a steadily increasing dividend payout. Myriad Genetics stock price history, gives the entire historical data for MYGN stock.